BREO ELLIPTA
BREO ELLIPTA
Approved
DIN Number
02408872
Drug Class
Human
Market Date
Nov 29, 2013
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02408872
AIG Number0254450003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03AK10 VILANTEROL AND FLUTICASONE FUROATE
Product Specifications
Dosage FormPowder
Route of AdministrationInhalation
AHFS Classification68:04.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
FLUTICASONE FUROATEActive
Strength: 100 MCG / ACT
Monograph: FLUTICASONE FUROATE
VILANTEROL (VILANTEROL TRIFENATATE)Active
Strength: 25 MCG / ACT
Monograph: VILANTEROL (VILANTEROL TRIFENATATE)